Ken Griffin Inspire Medical Systems, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$125.79 - $216.71 $3.21 Million - $5.53 Million	-25,500 Reduced 22.67%	87,000 $18.4 Million
Q2 2024 Aug 14, 2024	BUY	$133.83 - $251.19 $1.02 Million - $1.91 Million	7,600 Added 7.24%	112,500 $15.1 Million
Q1 2024 May 15, 2024	BUY	$165.3 - $226.0 $5.36 Million - $7.32 Million	32,400 Added 44.69%	104,900 $22.5 Million
Q4 2023 Feb 14, 2024	SELL	$125.26 - $203.83 $3.78 Million - $6.16 Million	-30,200 Reduced 29.41%	72,500 $14.7 Million
Q3 2023 Nov 14, 2023	BUY	$185.0 - $326.08 $8.44 Million - $14.9 Million	45,600 Added 79.86%	102,700 $20.4 Million
Q2 2023 Aug 14, 2023	BUY	$226.52 - $324.64 $3.51 Million - $5.03 Million	15,500 Added 37.26%	57,100 $18.5 Million
Q1 2023 May 15, 2023	SELL	$229.06 - $278.01 $14 Million - $17 Million	-61,000 Reduced 59.45%	41,600 $9.74 Million
Q4 2022 Feb 14, 2023	BUY	$164.02 - $259.76 $6.82 Million - $10.8 Million	41,600 Added 68.2%	102,600 $25.8 Million
Q3 2022 Nov 14, 2022	BUY	$170.68 - $226.46 $2.01 Million - $2.67 Million	11,800 Added 23.98%	61,000 $10.8 Million

397

27.5M

519K

590K

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $5.34B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.